Evrysdi (risdiplam) for the Treatment of Spinal Muscular Atrophy (SMA)
Evrysdi™ (risdiplam) is indicated for the treatment of spinal muscular atrophy (SMA). Credit: Business Wire.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more